Publicacións nas que colabora con Santiago Aguin Losada (11)

2025

  1. Circulating Cell-Free DNA Concentration as a Biomarker in Head and Neck Cancer

    Oral Diseases

  2. Real-world evidence of nivolumab monotherapy in advanced renal cell carcinoma from a multicenter retrospective cohort study by the Spanish Genitourinary Oncology Group

    BMC Cancer, Vol. 25, Núm. 1

2022

  1. Plasma cell-free DNA and circulating tumor cells as prognostic biomarkers in small cell lung cancer patients

    Translational Lung Cancer Research, Vol. 11, Núm. 10, pp. 1995-2009

2021

  1. Clinical potential of circulating free DNA and circulating tumour cells in patients with metastatic non-small-cell lung cancer treated with pembrolizumab

    Molecular Oncology, Vol. 15, Núm. 11, pp. 2923-2940

  2. Longitudinal CTCs gene expression analysis on metastatic castration-resistant prostate cancer patients treated with docetaxel reveals new potential prognosis markers

    Clinical and Experimental Metastasis, Vol. 38, Núm. 2, pp. 239-251

  3. Predictive value of ERCC2, ABCC2 and MMP2 of response and long-term survival in locally advanced head and neck cancer patients treated with chemoradiotherapy

    Cancer Chemotherapy and Pharmacology, Vol. 88, Núm. 5, pp. 813-823

2020

  1. Association of salivary human papillomavirus infection and oral and oropharyngeal cancer: A meta-analysis

    Journal of Clinical Medicine, Vol. 9, Núm. 5

  2. Detection of MET Alterations Using Cell Free DNA and Circulating Tumor Cells from Cancer Patients

    Cells, Vol. 9, Núm. 2

2019

  1. Association of GSTP1 and ERCC1 polymorphisms with toxicity in locally advanced head and neck cancer platinum-based chemoradiotherapy treatment

    Head and Neck, Vol. 41, Núm. 8, pp. 2704-2715

2013

  1. Prognostic value of changes in the expression of stem cell markers in the peripheral blood of patients with colon cancer

    Oncology Reports, Vol. 29, Núm. 6, pp. 2467-2472

  2. Zoledronic acid as an antimetastatic agent for different human tumor cell lines

    Anticancer Research, Vol. 33, Núm. 12, pp. 5295-5300